Locations
Billerica, MA, USA · North America
industry
Biotechnology · DeepTech · Health
Size
201-1000 employees
Stage
Other
founded in
2007
Quanterix is a leader in ultra-sensitive biomarker detection, utilizing its proprietary Simoa® technology to empower researchers in various therapeutic areas including neurology, oncology, immunology, and cardiology. The company offers a wide range of products such as assay kits, automated analyzers, and custom assay development services, which are designed to facilitate breakthroughs in disease detection and treatment. With a strong focus on precision health, Quanterix has established a significant market position, supported by hundreds of peer-reviewed publications and a growing client base. Their innovative approach not only enhances the reliability of biomarker quantification but also aims to transform healthcare by enabling earlier disease detection and improved patient outcomes.
Something looks off?